Tag: Dementia
Dementia May Occur Less Often, Develop Slower in Parkinson Disease Patients
Median time to dementia was 15 years in Penn cohort; estimated probability of dementia at year 10 was 9 to 15 percent in PPMI cohort
Population-Level Interventions Cost-Effective for Reducing Risk for Dementia
Interventions could reduce risk factors for dementia, resulting in cost-savings and gain in quality-adjusted life years
Plasma Biomarkers of Alzheimer Neuropathy Linked to Dementia Risk
Significant associations seen for all Alzheimer disease plasma biomarkers in late life with late-life dementia
Amyloid Probability Score 2 Has High Diagnostic Accuracy for Alzheimer Disease
Diagnostic accuracy 73 percent for dementia specialists compared with 91 percent using the APS2
Hormone-Modulating Therapy May Reduce Dementia Risk in Breast Cancer
Greatest reduction seen for women aged 65 to 74 years who self-identify as Black
Benzodiazepines Not Tied to Higher Dementia Risk in Older Adults
However, potential class-dependent associations may exist
Metformin, SGLT2 Inhibitors Exhibit Significantly Lower Dementia Risk
Metformin displayed lowest risk for dementia across diverse antidiabetics, while α-glucosidase inhibitors had highest risk
Nightmares in Midlife May Point to Future Cognitive Decline, Dementia
Findings seen in middle-aged and older adults from the general population, free from Parkinson disease
Models Constructed to Predict Decline Over Time in MCI, Mild Dementia
Hypothetical patients with MCI, baseline MMSE of 28, CSF Aβ1-42 of 925 pg/mL predicted to reach MMSE of 20 after 6.0 years
Dementia With Lewy Bodies Risk Down With α-1 Adrenergic Receptor Antagonists
Risk for developing DLB was lower for men newly started on Tz/Dz/Az compared with those taking tamsulosin or 5ARI
